Tomita, N., Kunieda, K., Maeda, A., Hamada, C., Yamanaka, T., Sato, T., . . . Maehara, Y. (2019). Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: Final results of the JFMC37-0801 study. Br J Cancer.
Chicago Stili AlıntıTomita, Naohiro, et al. "Phase III Randomised Trial Comparing 6 Vs. 12-month of Capecitabine As Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Final Results of the JFMC37-0801 Study." Br J Cancer 2019.
MLA AlıntıTomita, Naohiro, et al. "Phase III Randomised Trial Comparing 6 Vs. 12-month of Capecitabine As Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Final Results of the JFMC37-0801 Study." Br J Cancer 2019.